Cabot Corporation (CBT)
NYSE: CBT
· Real-Time Price · USD
79.49
0.09 (0.11%)
At close: Aug 20, 2025, 1:29 PM
Cabot Revenue Breakdown
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2012 |
|---|---|---|---|---|---|
| Performance Chemicals Revenue | 1.25B | 1.23B | 1.37B | 1.15B | 2.02B |
| Performance Chemicals Revenue Growth | +2.04% | -10.71% | +19.51% | -43.14% | n/a |
| Reinforcement Materials Revenue | 2.61B | 2.56B | 2.58B | 1.78B | n/a |
| Reinforcement Materials Revenue Growth | +1.83% | -0.47% | +44.58% | n/a | n/a |
Revenue by Geography
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
|---|---|---|---|---|
| Americas Revenue | 1.43B | 1.43B | 1.52B | 1.12B |
| Americas Revenue Growth | +0.63% | -6.06% | +35.57% | n/a |
| Asia Pacific Revenue | 1.52B | 1.49B | 1.59B | 1.26B |
| Asia Pacific Revenue Growth | +2.36% | -6.31% | +25.47% | n/a |
| Emea Revenue | 905M | 877M | n/a | n/a |
| Emea Revenue Growth | +3.19% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 62M | 64M | 66M | 73M | 68M | 75M | 67M | 69M | 58M | 66M | 60M | 62M | 51M | 74M | 71M | 89M | 68M | 71M | 61M | 62M | 52M | 114M | 64M | 82M | 65M | 70M | 73M | 84M | 74M | 78M | 69M | 69M | 63M | 65M | 63M | 78M | 64M | 62M | 71M | 66M | 67M | 71M |
| Selling, General, and Administrative Revenue Growth | -3.12% | -3.03% | -9.59% | +7.35% | -9.33% | +11.94% | -2.90% | +18.97% | -12.12% | +10.00% | -3.23% | +21.57% | -31.08% | +4.23% | -20.22% | +30.88% | -4.23% | +16.39% | -1.61% | +19.23% | -54.39% | +78.12% | -21.95% | +26.15% | -7.14% | -4.11% | -13.10% | +13.51% | -5.13% | +13.04% | 0.00% | +9.52% | -3.08% | +3.17% | -19.23% | +21.88% | +3.23% | -12.68% | +7.58% | -1.49% | -5.63% | n/a |
| Research and Development Revenue | 15M | 15M | 14M | 17M | 16M | 15M | 15M | 14M | 15M | 15M | 13M | 14M | 14M | 14M | 13M | 15M | 12M | 15M | 14M | 16M | 13M | 14M | 14M | 13M | 16M | 15M | 16M | 18M | 17M | 16M | 15M | 16M | 14M | 14M | 12M | 13M | 13M | 11M | 16M | 14M | 15M | 14M |
| Research and Development Revenue Growth | 0.00% | +7.14% | -17.65% | +6.25% | +6.67% | 0.00% | +7.14% | -6.67% | 0.00% | +15.38% | -7.14% | 0.00% | 0.00% | +7.69% | -13.33% | +25.00% | -20.00% | +7.14% | -12.50% | +23.08% | -7.14% | 0.00% | +7.69% | -18.75% | +6.67% | -6.25% | -11.11% | +5.88% | +6.25% | +6.67% | -6.25% | +14.29% | 0.00% | +16.67% | -7.69% | 0.00% | +18.18% | -31.25% | +14.29% | -6.67% | +7.14% | n/a |